A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis
Goldstein, Michael H., Tubridy, Karen L., Agahigian, Jennifer, Furfine, Eric, Magill, Marianne, Kovalchin, Joseph, Golden, Kathryn, Zarbis-Papastoitsis, Gregory, Soong, Fiona, Salapatek, Anne Marie, SТом:
41
Мова:
english
Журнал:
Eye & Contact Lens: Science & Clinical Practice
DOI:
10.1097/icl.0000000000000152
Date:
May, 2015
Файл:
PDF, 677 KB
english, 2015